Skip to main content
Bavarian Nordic logo

Bavarian Nordic — Investor Relations & Filings

Ticker · BAVA ISIN · DK0015998017 LEI · 2138006JCDVYIN6INP51 CO Manufacturing
Open in API
Filings indexed 2,307 across all filing types
Latest filing 2023-03-16 Share Issue/Capital Cha…
Country DK Denmark
Listing CO BAVA

About Bavarian Nordic

https://www.bavarian-nordic.com/

Bavarian Nordic is a fully integrated biotechnology company specializing in the research, development, manufacturing, and commercialization of life-saving vaccines. The company's portfolio targets infectious diseases, including vaccines for Mpox, rabies, and typhoid. It is a leading global provider of travel vaccines and serves as a key partner for governments and international organizations in addressing public health preparedness needs.

Recent filings

Filing Released Lang Actions
Share Issue/Capital Change 2023
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces a 'Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise'. This action involves the issuance of new shares following the exercise of warrants, which directly impacts the company's capital structure and share count. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). Although it involves shares, it is not a general share repurchase (POS) but a specific capital raising event via employee compensation instruments. It is not a general share issue (SHA) but a specific financing/capital structure change event.
2023-03-16 English
Share Issue/Capital Change 2023
Share Issue/Capital Change Classification · 99% confidence The document is titled "Selskabsmeddelelse" (Company Announcement) and explicitly details a capital increase ("Kapitalforhøjelse") resulting from employee stock option exercises. It specifies the nominal increase (DKK 908.460), the number of shares issued, the subscription prices, and the total proceeds (DKK 13.4 million). This directly relates to changes in the company's capital structure and share issuance. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). Although it involves options, the core event being announced is the resulting capital increase, not just the option exercise itself, making SHA more specific than CAP (Capital/Financing Update) or RNS (Regulatory Filings). The document length is relatively short, but it contains the full substance of the announcement, not just a notice that a report is attached.
2023-03-16 Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change Classification · 98% confidence The document is a corporate announcement from Bavarian Nordic A/S regarding a capital increase resulting from the exercise of employee stock options. It details the number of shares issued, the subscription prices, and the impact on the total share capital. This falls under the category of share issuance and capital changes. While it mentions a 'Vedhæftet fil' (attached file), the text itself provides the core information regarding the capital change, making it a primary announcement of a share issue rather than just a notification of a report publication.
2023-03-16 Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change Classification · 100% confidence The document is a company announcement detailing an increase in share capital resulting from the exercise of employee warrants. It specifies the number of new shares issued, the subscription prices, the total proceeds, and the updated total share capital. This falls directly under the definition of a share issue or capital change announcement.
2023-03-16 English
Director's Dealing 2023
Director's Dealing Classification · 100% confidence The document is explicitly titled "Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such." It details the 'Grant' of Restricted Stock Units (RSUs) to executives (President and CEO, CFO, EVP/CCO) and cites compliance with Article 19 of Regulation No. 596/2014 (Market Abuse Regulation). This type of filing, reporting insider transactions by management, directly corresponds to the definition of Director's Dealing (DIRS). The document is a formal report of transactions, not an announcement of a report (RPA/RNS).
2023-03-02 English
Remuneration Information 2023
Remuneration Information Classification · 99% confidence The document is titled "Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer" (Notification of transactions in the shares and related securities of Bavarian Nordic by persons discharging managerial responsibilities and persons closely associated with them). It explicitly references EU Regulation No 596/2014 and Commission Implementing Regulation (EU) 2016/523, which govern insider transactions and market abuse. The content details specific share allocations ('Tildeling' of 'Betingede aktier') to senior management (CEO, CFO, EVP) on a specific date (2023-03-02). This directly corresponds to the definition of Director's Dealing (insider trades by executives).
2023-03-02 Danish

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.